Antiallergic Non-Drug Supplement Market

Global Antiallergic Non-Drug Supplement Market Size, Share and Trends Analysis Report, By Product Type (Capsules, Tablets, and Liquids), By Application (Pollen Allergy, Dust Mites Allergy, and Others), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025219 | Category : Nutraceuticals & Functional Foods | Delivery Format: /

The global antiallergic non-drug supplement market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). An antiallergic non-drug supplement is a medicinal product that includes various types of nutritional supplements, oils, among others. These supplements are categorized into tablets, capsules, and liquid dosage forms. Antiallergic non-drug supplements can alleviate various types of allergic symptoms and enable allergic patients to deal with the allergic symptoms without using any chemical-based formulations for the treatment. 

The increasing prevalence of various allergic conditions such as fever, cough, cold, watery eyes, itching, sneezing, and others is anticipated to create new opportunities for the global antiallergic non-drug supplement market. The rising consumer preference to adopt natural and plant-based supplements is further expected to boost the growth of the global antiallergic non-drug supplement market. Additionally, the harmful effects associated with the use of chemical-based supplements is expected to surge the demand for non-drug supplement to treat several allergic conditions is further driving the market growth.

Some market players such as General Nutrition Center Holdings, LLC (GNC), Emerald Laboratories, and others have been adopted various strategies to boost the market. Technological advancement, new product launches, and mergers & acquisitions, among others, are some key strategies that are adopted by key vendors to remain competitive in the market. In addition, some research institutes are also working in this area. For instance, in April 2021, National Center for Complementary and Integrative Health (NCCIH) announced that butterbur is used to treat migraines and hay fever, also known as allergic rhinitis, and efficiently relieve allergic symptoms. Butterbur is one of the most promising non-drug antiallergic supplements useful in some allergy drugs formulations. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape- General Nutrition Center Holdings, LLC (GNC), Emerald Laboratories, and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Antiallergic Non-Drug Supplement Market Report Segmentation

By Product 

o Capsules

o Tablets  

o Liquids 

By Application

o Pollen Allergy 

o Dust Mites Allergy  

o Others

Global Antiallergic Non-Drug Supplement Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World